3655
-
Biologics: Targets & Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Biologics: Targets & Therapy
(402,165) Views
Editor in Chief Professor Doris Mangiaracina Benbrook
1177-5475
Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiencySabine Kroiss, Manuela Albisetti
Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
Mohamed Mahdi-Rogers, Yusuf A Rajabally
A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis
Stephen P Myers, Joan O’Connor, J Helen Fitton, et al.
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
Richard Quek, Suzanne George
Safety of etanercept in elderly subjects with rheumatoid arthritis
Alfredomaria Lurati, Mariagrazia Marrazza, Katia Angela, et al
Recombinant follitropin alfa/lutropin alfa in fertility treatment
Ahmed Gibreel, Siladitya Bhattacharya
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed
